Bayesian Capital Management, LP Spring Works Therapeutics, Inc. Transaction History
Bayesian Capital Management, LP
- $838 Million
- Q3 2024
A detailed history of Bayesian Capital Management, LP transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Bayesian Capital Management, LP holds 19,414 shares of SWTX stock, worth $714,629. This represents 0.07% of its overall portfolio holdings.
Number of Shares
19,414
Previous 8,814
120.26%
Holding current value
$714,629
Previous $332,000
87.35%
% of portfolio
0.07%
Previous 0.04%
Shares
3 transactions
Others Institutions Holding SWTX
# of Institutions
237Shares Held
68.9MCall Options Held
144KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA6.71MShares$247 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$207 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.84MShares$141 Million4.54% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.52MShares$129 Million0.01% of portfolio
-
Boxer Capital, LLC San Diego, CA3.42MShares$126 Million5.82% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.3B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...